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(ZZ)-Muconaldehyde reacted with primary amines to give N-substituted-2-(2'-oxoethyl)-pyrroles,
which were reduced to N-substituted-2-(2'-hydroxyethyl)-pyrroles by sodium borohydride. The
pyrrole-forming reaction is exhibited by valine and its methyl ester, and is being developed with
terminal valine in hemoglobin as a means of dose monitoring (Z,Z)-muconaldehyde, a putative
metabolite of benzene. Reactions in aqueous solution between (Z,Z)-muconaldehyde and
adenosine, deoxyadenosine, guanosine, or deoxyguanosine leading to pyrrole-containing adducts
are described. The elucidation of the structures of the adducts was assisted by the study of
reactions between (Z,Z)-muconaldehyde and both nucleoside derivatives and a model compound
for guanosine. Reactions of (Z,Z)-muconaldehyde are complicated by its isomerization to (E,Z)-
and (E,E)-muconaldehyde. The kinetics of this process have been studied in benzene,
acetonitrile, and dimethylsulfoxide. - Environ Health Perspect 104(Suppl 6):1201-1209 (1996)
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Introduction
Following the discovery that (E,E)-
muconaldehyde is a metabolite ofbenzene
(1), it was of interest and importance to
determine the contribution of the mucon-
aldehyde isomers la to 1c (seeAppendix for
all structures) to the toxic effects of ben-
zene on humans. (E,E)-Muconaldehyde Ic
may be derived from the (E,Z)-isomer lb,
which is formed by isomerization of the
(Z,Z)-isomer la, the putative primary prod-
uct of the oxidative cleavage of benzene.
Scheme 1 shows a possible route (2,3) from
benzene to la, in which the oxidant is either
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cytochrome P-4502E1 in metabolism or a
powerful chemical oxidant [e.g., 2-methyl-
2-trifluoromethyldioxirane, which converts
benzene into a mixture of lb and Ic,
presumably via la (4)]. Muconaldehydes
are obviously ox,f-unsaturated aldehydes
and may therefore be expected to exhibit
properties analogous to those of acrolein,
for example, which is known to react
with DNA to form cyclic adducts (5,6).
However, muconaldehydes duplicate
acrolein functionality and have the poten-
tial to cross-link biomolecules. We wish to
determine the nature ofthe interactions of
muconaldehydes with nucleic acids and
proteins because these interactions may be
relevant to the toxicity of benzene (7).
Adducts ofmuconaldehydes with DNA or
0
P450-dependent
monooxygenase
i Co
hemoglobin might be found in animals and
humans exposed to benzene. Adducts with
hemoglobin might be useful for dose mon-
itoring, while adducts with DNA might be
indicative ofan oncogenic pathway.
This article describes a detailed study of
the behavior of muconaldehyde isomers
in solution, their reactions with amine
nucleophiles including amino acids and
nucleosides, and a preliminary study of
their reactions with DNA and a terminal
heptapeptide ofhemoglobin.
Materials and Methods
Chemicals, Reagents, andSolvents
All chemicals and reagents used were
obtained commercially and were purified
where necessary by standard procedures (8).
N-(Benzyloxycarbonyl)-L-lysine benzyl ester
benzenesulfonate was purchased from
Bachem (Bachem Feinchemikalien AG,
CH-4416 Bubendorf, Switzerland). Sodium
methoxide in methanol solutions were
prepared by dissolving sodium metal in
methanol under nitrogen. The resultant
sodium methoxide solution was assayed by
titration with standard hydrochloric acid
using bromothymol blue as indicator.
Solvents used for reactions of mucon-
aldehyde were ofhigh performance liquid
chromatography (HPLC) grade or were
purified by standard procedures (8).
Dimethylformamide was purified by stand-
ing over molecular sieves (3 A) for 24 hr,
distilling from phosphorus pentoxide onto
molecular sieves (3 A), and storing under
nitrogen. Dichloromethane was passed
through basic alumina immediately prior
to use.
Methods
Solvents were removed on a rotary evapo-
rator under reduced pressure at ambient
temperature, except for dimethylforma-
mide, which was removed by short path
distillation under high vacuum at < 500C.
,-oz P450-dependent 0
C01* monooxygenase
Scheme 1. Proposed route (2,3) forthe conversion of benzene into(Z,Z)-muconaldehyde.
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Residual volatile solvents were also removed
from samples (e.g., for preparation ofsam-
ples for submission for analysis) under high
vacuum. Molecular sieves were activated
prior to use byheatingwith a Bunsen burner
and cooling in a desiccator. Thin-layer chro-
matography (TLC) was performed on alu-
minum-backed Kieselgel 60 F254 (Merck
Ltd., Poole BH15 1BR, UK) or Merck 5550
(Merck Ltd., Poole BH15 1BR, UK) neutral
aluminaplates. Developed plates werevisual-
ized by examination under an ultraviolet
light source or by contact with molyb-
dophosphoric acid in ethanol solution fol-
lowed by heating. Column chromatography
was performed on Kieselgel 60 or neutral
alumina under pressure. Solvents for col-
umn chromatography were HPLC grade or
redistilled laboratory grade. HPLC analyses
were performed using a Jones chromatogra-
phy reverse phase [Spherisorb ODS (5 4)]
column (25 x 0.46 cm) Uones Chromatog-
raphy Ltd., Hengoed CF8 8AU, Wales)
with gradient elution in which solvent A
was water and solvent B was methanol. All
analyses were performed using a pump pro-
gram that delivered the same gradient and
differed only in total time for the analysis.
The gradientwas 0.67% B min'.
Instnumentation
HPLC analyses were performed on a
Merck-Hitachi L-6200A intelligent pump
fitted with a Merck-Hitachi L-4500 ultra
violet diode array detector (Merck Ltd.,
Poole BH15 1BR, UK) and a Rheodyne
injector (Rheodyne Inc., Cotati, CA94928).
Infrared spectra were recorded on either
a Nicolet 20-SXB FTIR spectrophotometer,
or on aNicolet 20-PCIRspectrophotometer
(Nicolet Instruments Ltd., Warwick CV34
5XH, UK). Samples were run using KBr
disks or as films on NaCl plates. Peaks are
designated by theirwavenumber (cm-').
Ultraviolet spectra were recorded on a
Kontron Uvikon-810 spectrophotometer
(Kontron AG, CH-8010 Zurich, Switzer-
land). Samples were run in solution in
HPLC grade methanol or acetonitrile. All
absorbances are quoted by their Xmax (nm)
values followed in brackets by the extinc-
tion coefficient. When appropriate, the
absorption may be described as a "shoulder"
designated "sh."
Mass spectra were recorded on a Kratos
MS80 RF spectrometer (ElectroMed Ltd.,
Trafford Park, Manchester M17 1QS, UK).
Samples were analyzed by either electron
impact (EI) or fast atom bombardment
(FAB) mass spectrometry as indicated. All
peaks are quoted as m/zfollowed in brackets
by their percent intensity and, where possi-
ble, the fragment ion to which they corre-
spond. The molecular ion (where present)
is designated by M+.
'H NMR (nuclear magnetic resonance)
spectra were recorded on a Bruker WP-200
(200 MHz) or a Bruker WM-300 (300
MHz) spectrometer (Bruker Spectrospin
Ltd., Coventry CV4 9GH, UK). Peaks are
assigned by their chemical shift in parts per
million followed in brackets by their multi-
plicity (s, singlet; d, doublet; t, triplet q,
quartet; dd, double doublet; and m, multi-
plet), their spin-spin coupling constants
(J) in Hertz (where appropritate), and
their relative integral values in number of
protons to which it equates. All samples
were run as solutions in an appropriate
deuteriated solvent (commonly MeCN-d3,
Me2SO-d6, or dimethylformamide-d7)
using the residual nondeuteriated solvent
peak as an internal standard.
13C NMR were recorded on a Bruker
WP-200 (50 MHz) or a Bruker WM-300
(75 MHz) spectrometer operated in a
broad-band decoupling mode. Peaks are
assigned by their chemical shift in parts
per million.
SyntheticChemistry
Improved Preparation ofN-[(S)-1'-
(Methoxycarbonyl)-2'-methyl-n-propyl]-2-
(2'-hydroxyethyl)pyrrole 2c. A suspension
of L-valine methyl ester hydrochloride (23
mg, 1.4 x 10-4 mol) and sodium carbonate
(15 mg, 1.4 x 10-4 mol) in acetonitrile (2
ml) was stirred for 10 min at 20°C. A solu-
tion of (Z,Z)-muconaldehyde (9) (15 mg,
1.4 x 10A mol) in acetonitrile (2 ml) was
added subsequently. After stirring for 15
min the solvent was removed under reduced
pressure and the reaction mixture redis-
solved in methanol (4 ml). Sodium boro-
hydride (16 mg, 4.2 x 10-4 mol) was
added and the mixture stirred for 15 min.
The solvent was removed in vacuo, the
residue taken up in diethyl ether and dried
(MgSO4). Removal ofthe ether afforded
the crude product, which was purified by
column chromatography (elution with 1:1
ethyl acetate-petrol ether) to give N-[(S)-
1'-(methoxycarbonyl)-2'-methyl-n-propyl]-
2-(2'-hydroxyethyl)pyrrole 2c, (20 mg,
8.9 X 10-5 mol, 64%).
The material obtainedwas identical with
previously prepared as by 'H NMR (10).
Reaction of(ZZ)-Muconaldebyde with
2-Amino-4-hydroxy-6-methylpyrimidine
3a to Afford 4,5-Dihydro-5-hydroxy-8-
methylpyrrolo[l',2':3,4]pyrimido[2,1-
b]pyrimidine-6-one 3b. 2-Amino-4-
hydroxy-6-methylpyrimidine 3a (671 mg,
5.36 x 10-3 mol) was dissolved in dimethyl-
formamide (110 ml) by heating to near
reflux under nitrogen and allowing the
solution to cool to room temperature. To
the resulting solution was added (Z,Z)-
muconaldehyde (648 mg, 5.89 x 10-3 mol)
in dimethylformamide (20 ml) in one por-
tion, and pyridinium p-toluenesulfonate
(148 mg, 5.89 x 104 mol) in dimethylfor-
mamide (10 ml) (nb total volume of
dimethylformamide used = 160 ml, includ-
ing that used on each transfer). The reac-
tion mixture was stirred under nitrogen in
the dark at room temperature for 21 days.
The solvent was removed in vacuo. The
residue was partially dissolved in methanol
(200-250 ml) and the resultant suspension
filtered. The methanolic filtrate was evapo-
rated onto silica gel 60 in vacuo, and sub-
jected to medium pressure chromatography
on silica gel 60 (elution with ethyl acetate)
to give the crude product. This was rechro-
matographed on silica gel 60 (elution with
7:3 ethyl acetate-dichloromethane). The
partially purified product was washed with
acetone to afford purified 4,5-dihydro-5-
hydroxy-8-methylpyrrolo[1',2':3,4]pyrim-
ido[2,1-b]pyrimidine-6-one 3b as a white
solid (61 mg, 2.81 x 10-4 mol, 5.2%). A
further small quantity of the product was
recovered from the acetone washings. After
removal ofthe acetone in vacuo, the residue
was dissolved in methanol and passed
through activated charcoal to afford 4,5-
dihydro-5-hydroxy-8-methylpyrrolo[1',2':
3,4]pyrimido[2,1-b]pyrimidine-6-one 3b
(16.0 mg, 7.37 x 10-5 mol, 1.4%).
'H NMR (200 MHz, Me2SO-d6): 6 =
2.30 (d, J 0.6 Hz, 3H, Me), 3.23 (br,
2H, CH2), 6.21 (q,J0.8 Hz, 1H, 7-H),
6.24 (dd, J2-H,3-H 3.0 and Jl-H,3-H 1.4
Hz, 1H, 3-H), 6.40 (t, J2-H,3-H 3.2 and
J1-H,2-H 3.2 Hz, 1H, 2-H), 6.52 (br,
1H, CHOH), 7.16* (br, 1H, CHOH),
7.56 (dd, JI-H,3-H 1.5 and JI-H,2-H 3.2
Hz, 1H,1-H). *This signal disappears
on shaking with D20. '3C NMR (126
MHz, Me2SO-d6): 6 = 23.59 (q, Me),
28.56 (t, CH2), 70.77 (d, CHOH),
107.55, 109.73, 112.59, 116.72 (all d,
1-C, 2-C, 3-C, and 7-C), 125.99,
144.80 (both s, 3a-C and 8-C), 160.22,
163.53 (both s, 9a-C and 6-C). EI-MS:
m/z (%) = 217 (6, M+), 199 (100, M+-
H20), 170 (41), 143 (25), 118 (15),
109 (30), 80.(40), 69 (17); found
217.0854 (calcd for CIIHIIN302:
217.0851). X.max (MeOH) 231 nm
(log £ = 3.99), 247 (log £ = 4.00), 298
(log £ = 4.21). Vmax (KBr disk) 471,
532, 610, 637, 698, 739, 808, 833, 868,
912, 1070, 1111, 1138, 1190, 1281,
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1314, 1337, 1372, 1393, 1428, 1491,
1528, 1653, 3137, 3450 (br) cm-1.
Reaction of(ZZ)-MuconalUieyde uith
2,3,5-Tri-O-acetylguanosine to Afford
4,5-Dibydro-5-hydroxy-9-0-D-tri-O-acetyl-
ribosylpyrrolo[l',2'.3,4]-pyrimido[1,2-
a]purin-6(9H)-one 4a and9-P-D-Tri-
O-acetylribosylpyrrolo[1',2' :3,4]-
pyrimido[1,2-a]purin-6(9H)-one 5a. To a
solution of 2,3,5,-tri-O-acetylguanosine
(562 mg, 1.37x 10-3 mol) in dimethyl-
formamide was added a solution of (Z,Z)-
muconaldehyde (151 mg, 1.37 x 10-3
mol) in dimethylformamide in one portion
and a solution ofpyridinium p-toluenesul-
fonate (35.2 mg, 1.40 x 10-4 mol) in
dimethylformamide in one portion (total
volume ofdimethylformamide used, 33 ml).
The reaction mixture was stirred under
nitrogen, in the dark at 760C for 5 days.
The solvent was removed in vacuo. The
residue was partially dissolved in methanol
(125 ml) and filtered. The methanolic
filtrate was evaporated onto silica gel 60 in
vacuo, and subjected to medium pressure
chromatography on silica gel 60 (elution
with 1:1 ethyl acetate-acetone) to give the
crude product mixture. This was rechro-
matographed on silica gel 60 (elution with
4:1 ethyl acetate-acetone), and the partially
purified, separated products each passed
through activated charcoal to afford 4,5-
dihydro-5-hydroxy-9-p-D-tri- O-acetyl-
ribosylpyrrolo[1',2':3,4]-pyrimido[1,2-a]p
urin-6(9R)-one 4a (31.8 mg, 6.35 x 10-5
mol, 5%) and a small quantity of impure
9-P-D-tri-O-acetylribosylpyrrolo[1',2':3,4]-
pyrimido[1,2-a]purin-6(9H)-one 5a.
4,5-Dihydro-5-hydroxy-9-0-D-tri-O-
acetylribosylpyrrolo[l',2'.3,41-pyrim-
ido[1,2-a]purin-6(9I)-one 4a.
'H NMR (200 MHz, dimethylforma-
mide-d7): = 2.12 (s, 3H, 5'-OCOCH3),
2.147 (s, i15H, 3'-OCOCH3), 2.152 (s,
il5H, 3'-OCOCH3), 2.176 (s, 1i5H,
2'-OCOCH3), 2.186 (s, 1.5H, 2'-
OCOCH3), 3.32 (br m, 2H, 4-CH2),
4.25-4.59 (complex multiplet, 3H,
5'-CH2 and 4'-H), 5.85-5.97 (complex
multiplet, 1H, 3'-H), 6.09-6.16 (com-
plex miltiplet, IH, 2'-H), 6.22 (br m,
1H, 3-H), 6.33-6.38 (i, 2H, 2-H and
1'-H), 6.79 (m, IH, 5-H), 7.21-7.25
(m, LH, OH), 7.80 (ddJI-H,2-H 3.1 and
J1-H,3-H 1.3 Hz, 0.5H, 1-H), 7.85 (dd4
J1-H,2-H 3.2 and JI-H,3-H 1.3 Hz, 0.5H,
1-H), 8.30 (brs, 1H, 8-H). EI-MS: m/z
(%) = 501 (1.4, M+), 483 (6.4, M+-
H20), 441 (0.7, M+-AcOH), 259 (13,
[tri-O-AcRib]+), 225 (20, [M-H20-tri-
O-AcRib+H)]+), 139 (35), 115 (10), 97
(20), 80 (100), 62 (13), 50 (98); found
501.1541 (calculated for C22H23N509:
501.1496). TLC [silica gel 60 (4:1 ethyl
acetate-acetone)]: Rf = 0.30.
9-f -D-Tri-O-acetylribosylpyrrolo
[1',2'3,4]-pyrimido[1,2-aJpurin-6(9H)-
one5a.
'H NMR (200 MHz, dimethylforma-
mide-d7): 6= 1.90 (s, 3H, 5'-OCOCH3),
2.09 (s, 3H, 3'-OCOCH3), 2.14 (s, 3H,
2'-OCOCH3), 4.27 (m, 1H, 4'-H),
4.40-4.50 (i, 2H, 5'-CH2), 5.86 (x, J
5.9 Hz, 1H, 3'-H), 6.05 (dd J3.6 and
J5.9 Hz, 1H, 2'-H), 6.16 (d,J3.8 Hz,
1H, 1'-H), 6.64 (dd, J2-H,3-H 3.6 Hz,
1H, 3-H), 6.87 (t, J1-H,2-H 3.2 and
J2-H,3-H 3.2 Hz, 1H, 2-H), 7.10 (d,
J4-H,5-H 8.0 Hz 1H, 4-H), 7.96 (s, 1H,
8-H), 8.18 (d, J4-H,5-H 8.0 Hz, 1H, 5-
H), 8.28 (dd, J1-H,2-H 3.2 Hz, 1H, 1-
H). EI-MS: m/z (%) = 483 (12, M+),
279 (40), 225 (23, [M-tri-O-AcRib+
H]+), 139 (35), 113 (18), 97 (20), 83
(35), 77 (18), 69 (60), 55 (75), 43
(100), 32 (43); found 483.1444 (calcu-
lated for C22H21N508: 483.1390). TLC
[silica gel 60 (4:1 ethyl acetate-ace-
tone)]: Rf= 0.60.
Preparation of 4,5-Dihydro-5-
hydroxy-9-f3-D-ribosylpyrrolo[l',2'.3,4]-
pyrimido[1,2-a]purin-6(9H)-one 4efrom
4,5-Dihydro-5-hydroxy-9-p-D-tri-O -
acetylribosylpyrrolo[l',2'.3,4]-pyrim-
ido[1,2-a]pu-in-6(9H)-one 4a. A solution
of 4,5-dihydro-5-hydroxy-9-3-D-tri-O-
acetylribosylpyrrolo[1 ',2':3,4]-pyrim-
ido[1,2-a]purin-6(9H)-one 4a (15.0 mg,
2.99 x 10-5 mol) in methanol (2.5 ml) was
treated with a catalytic quantity ofsodium
methoxide (1.96 pl ofa 2.29-M solution in
methanol, 5 mol% per acetate function),
and the mixture was stirred for 22 hr at
room temperature. A further quantity of
sodium methoxide (1.00 pl of a 2.29-M
solution in methanol) was added, and the
mixture stirred for 4 hr at room tempera-
ture. Excess of Dowex-50 X8 (H+ form)
was added and the mixture was stirred for
30 min at room temperature. The solvent
was removed in vacuofrom the filtered mix-
ture. The residue was subjected to medium
pressure chromatography on silica gel 60
(elution with 7:1 acetone-methanol) to
give a fraction that was washed with a small
volume ofacetone to afford 4,5-dihydro-5-
hydroxy-9-p-D-ribosylpyrrolo[1',2':3,4]-py-
rimido[1,2-a]purin-6(9H)-one 4c as a white
solid (9.8 mg, 2.61 x 10-5 mol, 87%).
'H NMR (200 MHz, dimethylforma-
mide-d7): 6 = 3.33 (br m, 2H, 4-CH2),
3.81 (br m, 2H, 5'-CH2), 4.12(m, 1H,
4'-H), 4.42 (br, 1H, 3'-H), 4.78 (m, J
5.5 Hz, 1H, 2'-H), 5.20 (m, 1H, 5'-
OH), 5.37 (brd, 1H, 3'-OH), 5.74 (br
d, 1H, 2'-OH), 6.06 (d, J5.7 Hz, 1H,
1'-H), 6.22 (m, 1H, 3-H), 6.37 (t,
J2-H,3-H andJ1-H,2-H 3.3Hz, IH, 2-H),
6.81 (m, iH, 5-H), 7.21 (d, IH, 5-
OH), 7.64 (m, IH, 1-H), 8.38 (s, 1H,
8-H). 13C NMR (50 MHz, dimethyl-
formamide-d7): 6 = 60.69 (5'-C), 69.73,
70.52, and 73.69 (2', 3', and 4'-C),
84.95 and 86.96 (1' and 5'-C), 108.09,
11.04, and 115.76 (1, 2, and 3-C),
124.89 (3a-C), 137.46 (8-C). FAB-MS:
m/z (%) = 376 (30, MH+), 361 (45),
307 (20), 289 (18), 244 (35, MH+-
Rib +H), 226 (20, MH+-H2O-Rib +
H), 117 (17), 89 (22). Xmax (MeOH)
265 (loge = 3.86), 298 (logE = 3.94).
Preparation of9-P-D-Ribosylpyrrolo
[1',2':.3,4]-pyrimido[1,2-a]purin-6(9H)-
one Sbfrom 9- -D-Tri-0-acetylribosyl-
pyrrolo[l',2':3,41-pyrimido[1,2-
a]purin-6(9H)-one 5a. A solution of the
9-p-D-tri-O-acetylribosylpyrrolo[1',2':3,4]-
pyrimido[1,2-a]purin-6(9H)-one 5a (1.5
mg, 3.1 x 106 mol) in methanol (0.50 ml)
was treated with a catalytic quantity of
sodium methoxide (21 pl of a 0.023-M
solution in methanol, 5 mol% per acetate
function), and the mixture was stirred for
48 hr at room temperature. A further
quantity ofsodium methoxide (21 pl of a
0.023-M solution in methanol) was added,
and the mixture stirred for 4 hr at room
temperature. The solvent was removed in
vacuo and the residue subjected to medium
pressure chromatography on silica gel 60
(elution with 7:1 acetone-methanol) to
give the crude product. This was subjected
to reverse-phase HPLC on 5 p ODS (iso-
cratic elution with 2:5 methanol-water) to
afford 9-p-D-ribosylpyrrolo[1',2':3,4]-
pyrimido-[1,2-a]purin-6(9H)-one 5b as a
white solid (0.8 mg, 2.2 x 106 mol, 72%).
'H NMR (300 MHz, dimethylfor-
marnide-d7): 6 = 3.84 (d4 Jgm 12.0 and
J4'-H,5'-H 3.8 Hz, 1H, 5'-CH2), 3.92 (4W
Jgem 12.2 andJ4'-H,S-H 3.6 Hz, 1H, 5'-
CH2), 4.18 (ni, 1H, 4'-H), 4.50 (t,J4.4
Hz, IH, 3'-H), 4.81 (t,J5.2 Hz, 1H, 2'-
H), 4.96 (ni, IH, 5'-OH), 5.41 (br, IH,
3'-OH), 5.67 (br, IH, 2'-OH), 6.20 (d,
Jl'-H,2'-H 5.5 Hz, 1H, 1'-H), 6.75 (da4J2_
H,3-H 3.6 andJI-H,3-H 1.4Hz, IH, 3-H),
6.97 (t, J2-H,3-H andJI-H,2-H 3.4Hz, 1H,
2-H), 7.31 (d, J4-H,5-H 8.0 Hz, IH, 4-
H), 8.22 (dd, J1-H,2-H 3.0 and JI-H,3-H
1.3 Hz, IH, 1-H), 8.28 (d, J4-H,5-H 8.0
Hz, IH, 5-H), 8.54 (s, IH, 8-H). El-
MS: m/z (%) = 225 (15, M+-rib+H),
143 (20), 91 (23), 80 (52), 69 (20), 50
(45), 44 (100), 32 (58, CH30H+).
Reaction of(Z,Z)-Muconaldehyde
with 3,5-Di-0-acetyl-2'-deoxyguanosine
to Afford4,5-Dibydro-5-hydroxy-9-0-D-
di-O -acetyl-2-deoxyribosyl-
pyrrolo-[1',2':3,41-pyrimido[1,2-a]
Environmental Health Perspectives * Vol 104, Supplement 6 - December 1996 1203BLEASDALE ETAL.
purin-6(9H)-one 4b. To a solution of3,5-
di-O-acetyl-2'-deoxyguanosine (390 mg,
1.11 x 10-3 mol) in dimethylformamide
was added a solution of (Z,Z)-muconalde-
hyde (123. mg 1.12 x 10-3 mol) in
dimethylformamide in one portion and a
solution ofpyridinium p-toluenesulfonate
(28.0 mg, 1.11 x 104 mol) in dimethyl-
formamide in one portion (total volume
dimethylformamide used = 27 ml). The
reaction mixture was stirred under nitrogen
in the dark at 800C for 5 days. The solvent
was removed in vacuo, the residue partially
dissolved in methanol (100 ml), and
filtered. The methanolic filtrate was evapo-
rated onto silica gel 60 in vacuo, and sub-
jected to medium pressure chromatography
on silica gel 60 (elution with acetone) to
yield the crude product. This was rechro-
matographed on silica gel 60 (elution with
1:1 ethyl acetate-acetone) to afford 4,5-
dihydro-5-hydroxy-9-0-D-di-O-acetyl-2'-
deoxyribosylpyrrolo[1',2':3,4]-pyrimido[1,
2-a]purin-6(9H)-one 4b (15.6 mg, 3.52 x
10-5 mol, 3%).
'H NMR (200 MHz, dimethylfor-
mamide-d7): 6 = 2.03 (s, i15H, 5'-
OCOCH3), 2.07 (s, 1.5H, 5'-OCOCH3),
2.13 (m,2H, 2'-CH2), 2.15 (s, 1.5H, 3'-
OCOCH3), 2.18 (s,1.5H, 3'-OCOCH3),
3.33 (br m, 2H, 4-CH2), 4.08-4.27
(complex multiplet, 3H, 5'-CH2 and
4'-H), 5.61-5.69 (complex multiplet,
IH, 3'-H), 6.24 (br m, 1H, 3-H),
6.34-6.42 (complex multiplet, 1H, 2-
H), 6.52 (br t, J7.0 Hz, 1H, 1'-H),
6.82 (br m, 1H, 5-H), 7.25 (br d, J4.9
Hz, 1H, OH), 7.72 (dd, J1-H,2-H 3.1
andJl-H,3-H 1.5 Hz, 0.5H, 1-H), 7.76
(dd, Jl-H,2-H 2.8 and Jl-H,3-H 1.6 Hz,
0.5H, 1-H), 8.12 (s, 0.5H, 8-H), 8.14
(s, 0.5H, 8-H).
Preparation of 4,5-Dihydro-5-
hydroxy-9- -D-2'-deoxyribosylpyrrolo-
[I',2':3,4]-pyrimido[1,2-a]purine-
6(9H)-one 4dfrom 4,5-Dihydro-5-
hydroxy-9-,B-D-di-O-acetyl-2'-deoxy-
ribosylpyrrolo[l',2':3,41-pyrimido
[1,2-aJpurine-6(9H)-one 4b. A solution
of 4,5-dihydro-5-hydroxy-9-13-D-di-0-
acetyl-2'-deoxyribosylpyrrolo- [1',2':3,4]-
pyrimido[1,2-a]purin-6(91H)-one 4b (7.0
mg, 1.58 x 10-5 mol) in methanol (1.25
ml) was treated with a catalytic quantity of
sodium methoxide (1.00 pl of a 2.29-M
solution in methanol, 7 mol% per acetate
function) and the mixture was stirred for
24 hr at room temperature. A further
quantity ofsodium methoxide (0.50 pl ofa
2.29-M solution in methanol) was added
and the mixture stirred for 1 hr at room
temperature. The methanolic solution was
passed through a column ofDowex-50 X8
(H+ form). The solvent was removed from
the eluate in vacuo and the residue was
subjected to medium pressure chromatog-
raphy on silica gel 60 (elution with 12:1
acetone-methanol) to afford 4,5-dihydro-
5-hydroxy-9- -D-2'-deoxyribosylpyr-
rolo[1',2':3,4]-pyrimido[1,2-a]purin-6
(9H)-one 4d as an off-white solid (3.6 mg,
1.00 x 10-5 mol, 63%).
'H NMR (300 MHz, dimethylfor-
mamide-d7): 6 = 3.36 (br m,2H, 4-
CH2), 3.77 (br d, J 11.7 Hz, 1H,
5'-CH2), 3.84 (dd, J 11.6 and 4.5 Hz,
1H, 5'-CH2), 4.07 (br m, 1H, 4'-H),
4.70 (br m, 1H, 3'-H), 6.25 (d4, J3.0
and 1.4 Hz, 1H, 3-H), 6.41 (t, J2-H,3-H
3.2 andJ1-H,2-H 3.2 Hz, 1H, 2-H), 6.50
(br t,J6.8 Hz, IH, 1'-H), 6.84 (br t, J
2.7 Hz, IH, 5-H), 7.10-7.50 (br, IH,
5-OH), 7.68 (br m, IH, 1-H), 8.39 (s,
IH, 8-H). FAB-MS: m/z (%) = 360 (8,
MH+), 329 (4, MH+-CH2OH), 244
(14, MH+-dRib+H), 226 (6, MH+-
H20-dRib+H). X,max (MeOH) 265
(logE = 3.72), 297 (loge = 3.78).
Reaction of(Z,Z)-Muconaldehyde
withAdenine toAfford 7a/7b. To a solu-
tion ofadenine (189 mg, 1.39 x 10-3 mol)
in dimethylformamide (adenine was dis-
solved by warming in dimethylformamide)
was added a solution of pyridinium p-
toluenesulfonate (41.0 mg, 1.63 x 10-4
mol) in dimethylformamide in one por-
tion, and a solution of (Z,Z)-muconalde-
hyde (168 mg, 1.53 x 10-3 mol) in
dimethylformamide (total volume of
dimethylformamide used, 33 ml). The
reaction mixture was stirred under nitro-
gen, in the dark at 80°C for 3 days. The
solvent was removed in vacuo, the residue
was partially dissolved in methanol (80 ml)
and filtered. The methanolic filtrate was
evaporated onto silica gel 60 in vacuo, and
subjected to medium-pressure chromatog-
raphy on silica gel 60 (elution with 47:3
acetone-methanol) to yield the crude
product. This was rechromatographed on
silica gel 60 (elution with 100% acetone),
and finally on silica gel 60 (elution with
4:1 diethyl ether-methanol) to afford 7a or
7b (7.2 mg, 3.17 x 10-5 mol, 2.3%).
'H NMR (200 MHz, Me2SO-d6): 6 =
3.48 (br d, J 15.1 Hz, IH, CH2), 3.64
(ddJ5.3 and 15.1 Hz, IH, CH2), 6.27
(br d, J4.0 Hz, 1H, 5-H), 6.42-6.46
(complex miltiplet, J3.2 Hz, 2H, 3-H
and 2-H), 7.35 (br, IH, CHOH), 7.93
(d4 J 2.0 and J 3.1 Hz, 1H,1-H), 8.81
and 8.89 (both s, both IH, 6-H and
9-H). FAB-MS: mlz (%) = 288 (100,
MH+). Xmax (MeOH) 295 (log e =
3.93).
Reaction ofGuanosine with (Z,Z)-
Muconaldehyde inpH7Buffer. To a par-
tial solution of guanosine monohydrate
(27.3 mg, 9.06 x 10-5 mol) in sodium
phosphate buffer (0.1 M, pH 7) (2.17 ml)
was added (Z,Z)-muconaldehyde (9.9 mg,
9.00 x 10-5 mol). The mixturewas stirred at
35 to 400C in the dark, and the reaction was
analyzed periodically by HPLC for 8 days.
Reaction of2'-Deoxyguanosine with
(Z,Z)-Muconaldehyde in pH 7Buffer.
To a partial solution of2'-deoxyguanosine
monohydrate (28.4 mg, 1.00 x 10-4 mol)
in sodium phosphate buffer (0.1 M, pH 7)
(2.43 ml) was added (Z,Z)-muconaldehyde
(11.1 mg, 1.01 x 104 mol). The mixture
was stirred at 35 to 400C in the dark, and
the reaction was analyzed periodically by
HPLC for 7 days.
Reaction ofAdenosine with (Z,Z)-
Muconaldehyde in pH5.9 Buffer. To a
partial solution ofadenosine (27.0 mg, 1.01
x 104 mol) in sodium phosphatebuffer (0.1
M, pH 5.9) (2.45 ml) was added (Z,Z)-
muconaldehyde (11.2 mg, 1.02 x104 mol).
The mixturewas stirred at 35 to 400C in the
dark for 11 days. A sample ofthe reaction
mixture was then heated at 70°C for 3 days.
The reaction was analyzed periodically by
HPLC throughout the 14 days.
Reaction of 2'-Deoxyadenosine
with (Z,Z)-Muconaldehyde in pH 5.9
Buffer. To a partial solution of2'-deoxy-
gadenosine (23.8 mg, 8.84 x 10-5 mol) in
sodium phosphate buffer (0.1 M, pH 5.9)
(2.12 ml) was added (Z,Z)-muconaldehyde
(9.7 mg, 8.81 x 10-5 mol). The mixture
was stirred at 35 to 400C in the dark, and
the reaction was analyzed periodically by
HPLC for 8 days.
Reaction ofGuanosine with (Z,Z)-
Muconaldehyde in Aqueous Solution
Containing 10 mol% Pyridinium
p-Toluenesulfonate. To a partial solution
ofguanosine monohydrate (55.7 mg, 1.85
x 104 mol) in a solution ofpyridinium p-
toluenesulfonate (4.36 ml of a 4.22-mM
solution in water, 1.84 x 10-5 mol) was
added (Z,Z)-muconaldehyde (20.2 mg,
1.84 x 104 mol). The mixture was stirred at
35 to 40°C in the dark, and the reaction was
analyzedperiodically by HPLC for 9 days.
Reaction ofGuanosine with (Z,Z)-
Muconaldehyde in Water. To a partial
solution ofguanosine monohydrate (52.5
mg, 1.74 x 10-4 mol) in water (4.10 ml)
was added (Z,Z)-muconaldehyde (19.0
mg, 1.73 x 10-4 mol). The mixture was
stirred at 35 to 400C in the dark, and the
reaction was analyzed periodically by
HPLC for 9 days.
Environmental Health Perspectives * Vol 104, Supplement 6 * December 1996 1204MUCONALDEHYDE AND BENZENE TOXICOLOGY
Reaction of2'-Deoxyadenosine with
(Z,Z)-Muconaldehyde in Aqueous Solu-
tion Containing 10 mol% Pyridinium p-
Toluenesulfonate. To a partial solution of
2'-deoxyadenosine monohydrate (36.2 mg,
1.34 x 10-4 mol) in a solution of pyri-
dinium p-toluenesulfonate (3.24 ml of a
4.22-mM solution in water, 1.36 x 10-5
mol) was added (Z,Z)-muconaldehyde
(14.8 mg, 1.35 x 104 mol). The mixture
was stirred at 35 to 400C in the dark, and
the reaction was analyzed periodically by
HPLC for 5 days.
Results
Stabilityof(Z;Z)-Muconaldehyde in
Solution and Conversion into
(13Z)- and (13E)-Muconaldehyde
In variety of solvents, (Z,Z)-muconalde-
hyde undergoes a remarkable, highly
diastereoselective isomerization to (E,Z)-
muconaldehyde, which suffers either acid-
or base-catalyzed conversion into the ther-
modynamically stable end product, (E,E)-
muconaldehyde (9). Kinetic data for
isomerizations of (Z,Z)-muconaldehyde
into (E,Z)-muconaldehyde in benzene,
acetonitrile, and dimethylsulfoxide were
obtained by monitoring reactions by
'H NMR (Table 1).
The similarity in rate of isomerization
for a range of solvent polarity suggests a
thermally allowed electrocyclic process, as
shown in Scheme 2, in which 2-formyl-
2H-pyran interconnects (Z,Z)- and (E,Z)-
muconaldehyde (3,9). Analogous reactions
have been described, for example, the ring-
opening of2-alkenyl-2H-pyrans at room
temperature (11). The reaction in the
direction 2-formyl-2H-pyran -> (Z,Z)- or
(E,Z)-muconaldehyde can be analyzed by
considering the interaction of HOMO
diene with LUMO sigma (O/C-2 bond).
Hence, a disrotatory opening ofthis sigma
bond must occur, which gives (Z,Z)-mucon-
aldehyde if the hydrogen at C-2 moves
outward (and the formyl group moves
inwards), or (E,Z)-muconaldehyde if the
formyl group moves outward. Using the
data in Table 1, the following activation
parameters were calculated for the reaction
in acetonitrile-d3: Ea 89 ± 5 kJmol-1 and
ASt-99 ± 5 Jmol-1 k-1. The relatively
large negative entropy ofactivation is con-
sistent with the conversion of an acyclic
precursor into a cyclic transition state.
Studies of the isomerization of (Z,Z)-
and (E,Z)-muconaldehyde in water and
methanol were complicated by the forma-
tion of hydrates in water and acetals in
methanol. The major species formed could
be diagnosed by 'H NMR, e.g., 3 hr after
dissolution of (Z,Z)-muconaldehyde in
methanol-d4, the major species were
(E,Z)-muconaldehyde and an acetal (or
hemiacetal) of (E,Z)-muconaldehyde. In
protic solvents an alternative mechanism of
isomerization of(Z,Z)- into (E,Z)-mucon-
aldehyde needs to be considered (Scheme
3). This may explain the observation that
conversion of (Z,Z)- into (E,Z)-muconal-
dehyde is faster at higher pH. The cycliza-
tion process shown certainly occurs in basic
methanol because the the cis- and trans-
isomers of 2-(2'-hydroxyethyl)-5-meth-
oxy-2,5-dihydrofuran were isolated after
borohydride reduction (10). Further
information on the isomerizations of(Z,Z)-
into (E,Z)- and (E,E)-muconaldehyde in
waterand aqueous buffers is given in the sec-
tions on reactions of(Z,Z)-muconaldehyde
with nucleosides.
Reactions of(Z;Z)-Muconaldehyde
with SimpleAmines
We have previously reported (10) selected
reactions of (Z,Z)-muconaldehyde with
primary aliphatic and aromatic amines
leading to pyrrole-aldehydes 2a, probably
by the mechanism shown in Scheme 4.
These reactions proceed within minutes at
200C for a muconaldehyde concentration
of ca. 0.04 M with 1 mol equivalent of
amine. For amines ofhigh nucleophilicity
(e.g., propylamine), the yield ofproduct is
essentially quantitative in a variety of
solvents (e.g., water, methanol, dichloro-
methane or acetonitrile). The pyrrole-alde-
hydes 2a are relatively unstable, showing a
tendency to polymerize, probably by an
intermolecular condensation between the
aldehyde of one molecule and the free
pyrrole 0c-position of another. They are
best handled after reduction to the corre-
sponding pyrrole-alcohol 2b with sodium
borohydride. The reaction leading to a pyr-
role-aldehyde also occurs, albeit less cleanly,
with (E,Z)-muconaldehyde, but not with
the (E,E)-isomer because the mechanism
ofpyrrole formation (Scheme 4) requires
0
/
0
6o
Table 1. Rate constantsaforthe isomerization of(Z,Z)-
muconaldehyde into(E,Z)-muconaldehyde.
kx 107/51 kx 107/l1 kx 107/s'
T/K (C6A6) (CD3CN) [(CD3)2S0]
281 2.0 ± 0.05
289 7.9±0.2
309 150±4 73±1.9 54±1.4
328 1100±28 630± 16 400± 10
342 2900 ±73 1800 ±45 1600 ±40
aDetermined from the integral of the aldehyde reso-
nances observed in 'H NMR spectra. Typically, 30 to
35 mg of (Z,Z)-muconaldehyde was dissolved in 0.6 ml
of the chosen solvent (except for benzene, in which the
muconaldehyde was less soluble).
)a
HOMO
diene
Scheme 2. Mechanism proposed forthe conversion of(Z,Z)- into (E,Z)-muconaldehyde.
0
N OHHO
OH
,10
_ {
N
Scheme 3. Alternative mode (base-catalysed) of isomerization of(Z,Z)- to(E,Z)-muconaldehyde.
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Scheme 4. Mechanism offormation of pyrrole-aldehydes from (ZZ)-muconaldehyde and primary amines.
at least one Z double bond. (E,E)-
Muconaldehyde yields a mono-imine and
bis-imine product (with an excess of
amine) (10).
Reactions of(Z;Z)-Muconaldehyde
withAminoAcids andPeptides
We reported (10) that L-valine methyl ester
and N-(benzyloxycarbonyl)-L-lysine methyl
ester both react with (Z,Z)-muconalde-
hyde to afford pyrrole-alcohols 2c and 2d,
respectively, after borohydride reduction of
the initially formed pyrrole-aldehydes. In
an improved procedure, L-valine methyl
ester hydrochloride was treated with
(Z,Z)-muconaldehyde in acetonitrile con-
taining sodium carbonate for 15 min at
200 C. After addition of sodium borohy-
dride in methanol and strirring for 15 min,
a 64% yield of N-[(S)-1'-(methoxycar-
bonyl)-2'-methyl-n-propyl]-2-(2'-hydrox-
yethyl)pyrrole 2c was obtained. This
procedure was not satisfactory for unpro-
tected valine, but we found that the
tetraethylammonium salt of L-valine,
which is soluble in acetonitrile, gave 44%
of (S)-2-[2-(2'-hydroxyethyl)pyrrol-1-yl]-
3-methylpropanoic acid 2e on reaction
with (Z,Z)-muconaldehyde (10 min at
200C), followed by addition of sodium
borohydride in methanol.
It is well established that N terminal
valines in hemoglobin are a common site of
modification by reactive electrophiles [e.g.,
epoxides (12)]. We propose to develop
immunochemical procedures based on
hemoglobin valine adducts (13) for dose-
monitoring muconaldehyde. It should be
possible to raise monoclonal antibodies
specifically to a pyrrole adduct derived from
(Z,Z)-muconaldehyde and the N terminal
heptapeptide. The antibodies obtained can
be used in immunoaffinity enrichment pro-
cedures (14) to concentrate a valine-pyr-
role adduct from enzymic digests of
hemoglobin, thus permitting quantification
of the adduct by mass spectrometry. By
analogy with the reaction we observed for
(Z,Z)-muconaldehyde with valine (above),
it is expected that (Z,Z)-muconaldehyde
[and (E,Z)-muconaldehyde] will convert
the amino groups of N terminal valines
into pyrrole units. To help define this reac-
tion, the oc-chain N terminal heptapeptide
NH2-Val-Leu-Ser-Pro-Ala-Asp-Lys-OH (a
product ofthe digestion ofhemoglobin by
trypsin) has been synthezized by automated
synthesis. Reaction of this heptapeptide
with (Z,Z)-muconaldehyde in methanol
containing sodium carbonate (10 min at
200C), followed by addition of sodium
borohydride in methanol, gave an 85%
yield of a 1:1 pyrrole adduct, which is
subject to further investigation.
Reacdons of(ZZ)-Muconaldehyde
withNudeosides and
CalfThymus DNA
We have found that cyclic adducts are
formed from the reaction of(Z,Z)-mucon-
aldehyde with nucleosides and model
compounds for nucleosides. With such
compounds, the reaction is probably initi-
ated by an interaction between an exocyclic
amino group and (Z,Z)-muconaldehyde
leading to a pyrrole-aldehyde, the aldehyde
function of which is intramolecularly
trapped by a neighboring nucleophilic
nitrogen function (Scheme 5).
2-Amino-4-hydroxy-6-methylpyrimi-
dine 3a was chosen as a model compound
for the pyrimidine systems of guanosine
and deoxyguanosine in a reaction with
(Z,Z)-muconaldehyde. This reaction was
performed in dimethylformamide using
pyridinium p-toluenesulfonate as acid cata-
lyst (10 mol%) and gave the adduct 4,5-
dihydro-5-hydroxy-8-methylpyrrolo [1',2':
3,4]pyrimido[2,1-b]pyrimidine-6-one 3b
in 7% yield. The structure of3b was rigor-
ously established byX-ray analysis (Bleasdale
et al., unpublished results). In connection
with the acidic catalysis ofthe formation of
3b, we also observed that reactions of
anilines with (Z,Z)-muconaldehyde are
promoted by silica gel, and reactions of
aliphatic amines with (Z,Z)-muconalde-
hyde are much faster in dichloromethane
that has not been passed through basic
alumina prior to use.
The protected nucleosides tri-O-acetyl-
guanosine and di-O-acetyl-2'-deoxyguano-
sine were allowed to react at 80°C with
(Z,Z)-muconaldehyde under the dimethyl-
formamide/pyridinium p-toluenesulfonate
conditions. The adducts 4,5-dihydro-5-
hydroxy-9-p-D-tri-O-acetylribosylpyr-
rolo[1',2':3,4]-pyrimido[1,2-a]purin-6(9H)-
one 4a and 4,5-dihydro-5-hydroxy-9-P-D-
di-O-acetyl-2'-deoxyribosylpyrrolo-
[1',2':3,4]-pyrimido[1,2-a]purin-6(9H)-on
e 4b, respectively, were isolated from these
reactions and purified by medium pressure
chromatography. A small quantity of the
dehydrated adduct 9-p-D-tri-O-acetyl-
ribosylpyrrolo[1',2':3,4]-pyrimido[1,2-
a]purine-6(9H)-one 5a was isolated as a
by-product from the tri-O-acetylguanosine
reaction. Base-catalyzed methanolysis of
adducts 4a and 4b gave the adducts 4,5-
dihydro-5-hydroxy-9-p-D-ribosylpyrrolo-
[1',2':3,4]-pyrimido[1,2-a]purin-6(9H)-on
e 4c and 4,5-dihydro-5-hydroxy-9-P-D-2'-
deoxyribosylpyrrolo[1',2':3,4]-pyrimido-
[1,2-a]purin-6(9H)-one 4d, respectively,
which were used as standards for monitor-
ing reactions of unprotected nucleosides
with (Z,Z)-muconaldehyde under aqueous
conditions (below).
The assignment ofthe structures ofthe
guanosine and deoxyguanosine adducts (4c
0
O H 0
HN N
+ HN /jN
H2N
.
N
Scheme 5. Mechanism offormation ofcyclic adducts from (Z,Z)-muconaldehyde and guianosine derivatives.
Environmental Health Perspectives - Vol 104, Supplement 6 * December 1996 1206MUCONALDEHYDE AND BENZENE TOXICOLOGY
and 4d, respectively) was based primarily
on comparison of their 'H NMR spectra
with the IH NMR of the 2-amino-4-
hydroxy-6-methylpyrimidine adduct 3b.
The 1H NMR spectra ofadducts 4a and 4b
displayed duplication ofproton resonances
indicative ofa mixture ofdiastereoisomers.
The structure of adduct 5a was deter-
mined by noting that the resonances for
the 4-CH2, 5-CHOH, and 5-CHOH of
4a were absent from its 'H NMR, which
exhibited an AB system at 6 7.10 and 8.18
(J 8.0 Hz). Furthermore, its electron
impact mass spectrum showed a molecular
ion at mlz 483. Adduct 5a is obviously
derived by dehydration of4a. It was depro-
tected to afford adduct 5b. The pyrimidine
adduct 3b was dehydrated by heating in
dimethylformamide and afforded a mix-
ture of two compounds, one ofwhich is
believed to be the dehydrated species 6 by
comparison ofits iH NMRwith 5a.
Adenine was reacted with (Z,Z)-
muconaldehyde under similar conditions
to those described for di-O-acetyl-2'-de-
oxyguanosine to give an adduct for which
two alternative structures, 7a and 7b are
possible. Structure 7b is preferred because
an nOe was observed between the CHOH
and the resonance at higher 6 value
(assumed to be 8-H by analogy with ade-
nine). The adenine adduct 7a/7b gave a
retention time of 53 to 54 min under the
standard HPLC conditions.
The identification of adducts 4d and
7a/7b makes available reference standards
for a study of reactions of (Z,Z)-mucon-
aldehyde with oligonucleotides and DNA.
It is expected that adduct 7a/7b will be
spontaneously released from DNA as a con-
sequence of reaction with (Z,Z)-mucon-
aldehyde, whereas adduct 4d will require
enzymic digestion of modified DNA to
effect its release. Preliminary reactions of
(Z,Z)-muconaldehyde with calf thymus
DNA have been carried out. These involved
the addition of a 10 x molar excess of
(Z,Z)-muconaldehyde to a solution of
DNA in Tris buffer at pH 7.0, with heat-
ing at 37°C for 8 hr. As yet no adducts
have been isolated from these reactions.
Reactionof(Z4Z)-Muconaldehydewith
Nudeosides underAqueous Conditions
Reactions of (Z,Z)-muconaldehyde with
guanosine, 2-deoxyguanosine, adenosine
and 2'-deoxyadenosine under aqueous con-
ditions were studied using adducts prepared
by the dimethylformamide/pyridinium
p-toluenesulfonate and base-catalyzed
methanolysis chemistry (above) as HPLC
standards. The reactions were carried out
under both aqueous acidic and neutral
conditions at 35 to 40°C. Reverse-phase
HPLC of the reaction mixtures was per-
formed with ultraviolet diode array detec-
tion of the eluted compounds, allowing
"on-line" identification by comparison
with the standards. The adducts were
formed readily under acidic conditions for
all nucleosides and near neutral pH for
guanosine and 2'-deoxyguanosine. Deoxy-
adenosine showed ready formation of the
adenine adduct 7a/7b at pH 6 and tem-
perature of35 to 40°C. However, adeno-
sine required heating to give 7a/7b,
presumably to induce depurination of an
intact adduct, as expected on the basis of
the relative depurination rates ofadenosine
and 2'-deoxyadenosine.
Reactions of(ZZ)-Muconaldehyde
with Guanosine andDeoxyguanosine
underAqueous Conditions
The reaction of guanosine with (Z,Z)-
muconaldehyde was studied in pure water,
in aqueous solution containing 10 mol%
pyridinium p-toluenesulfonate, pH 3.5,
and in 0.1 M, pH 7.0, sodium phosphate
buffer. The guanosine adduct 4c appeared
within 3 hr under the pH 3.5 conditions as
judged by the retention time of the peak
(a reference standard for the guanosine
adduct 4c gave a retention time of47-48
min under the HPLC conditions used) and
its ultraviolet spectrum. After 24 hr there
was no (Z,Z)-muconaldehyde remaining,
with the most prevalent muconaldehyde
isomer being the (E,Z) form, while after 5
days the (E,E)-isomer predominated. In
pure water, in which the pH of the reac-
tion mixture varied within the range 4.0 to
5.5, adduct 4c was also apparent within 3
hr. The predominant muconaldehyde iso-
mer at 45 hrwas (E,Z)-muconaldehyde. In
pH 7 sodium phosphate buffer, adduct 4c
was also apparent in the first few hours.
The predominant muconaldehyde isomer
after 48 hr was the (E,E)-isomer.
The reaction of2'-deoxyguanosine with
(Z,Z)-muconaldehyde in 0.1 M, pH 7.0,
sodium phosphate buffer gave adduct 4d,
behaving in a similar manner to the guano-
sine reaction under these conditions (adduct
4d gave a retention time of 52-53 min
under the-HPLC conditions used).
Reactions of(ZZ)-Muconaidehyde
withAdenosine and2-Deoxyadenosine
underAqueous Conditions
The reaction of 2'-deoxyadenosine with
(Z,Z)-muconaldehyde was studied in
aqueous solution containing 10 mol%
pyridinium p-toluenesulfonate, in 0.1 M,
pH 6.0, sodium phosphate buffer, and in
0.1 M, pH 7.0, sodium phosphate buffer,
while the reaction of adenosine with
(Z,Z)-muconaldehyde was only performed
in 0.1 M, pH 6.0, sodium phosphate
buffer. 2'-Deoxyadenosine with (Z,Z)-
muconaldehyde in aqueous solution con-
taining 10 mol% pyridinium p-toluene
sulfonate gave the adenine adduct 7a/7b
(which was detected after 2.5 hr, and
clearly evident after 24 hr). Another prod-
uct (retention time of 43-44 min) was
observed in this reaction mixture, but was
not identified. When 2'-deoxyadenosine
and (Z,Z)-muconaldehyde were incubated
in 0.1 M, pH 6.0, sodium phosphate
buffer, the adduct 7a/7b was apparent
after 18 hr. The unknown product at 43
to 44 min, observed for the reaction with
10 mol% pyridinium p-toluenesulfonate,
was also apparent. Incubation of2-deoxy-
adenosine with (Z,Z)-muconaldehyde in
0.1 M, pH 7.0, sodium phosphate buffer
did not give the adduct 7a/7b. Adenosine
with (Z,Z)-muconaldehyde at pH 6 did
not appear to give the adenine adduct
7a/7b after 1 week at 35 to 40°C. Asample
ofthe reaction mixture was then heated to
700C andproduced adduct 7a/7b.
Discussion
In aqueous solution, muconaldehydes
exhibit a complex behavior in which iso-
merization of the isomers competes with
hydration reactions. In the presence of a
purine nucleoside, (Z,Z)-muconaldehyde
affords a tetracyclic adduct containing a
pyrrole ring derived from the mucon-
aldehyde (4d from 2-deoxyguanosine;
7a/7b from 2'-deoxyadenosine). The
structures ofthese adducts and the mecha-
nisms of their formation (Schemes 4,5)
have been inferred from studies of reac-
tions of(Z,Z)-muconaldehyde with simple
amines and model compounds for nucleo-
sides. If these kinds ofadduct are formed
in DNA, Watson-Crick hydrogen bonding
sites would be blocked. The pyrrole
adducts 4d and 7a/7b are structurally ana-
logous to known mutagenic cyclic adducts,
e.g., the etheno adducts implicated in
cancer caused by exposure to vinyl chlo-
ride (15,16) and ethyl carbamate (17).
However, assessment of the cancer risks
from muconaldehydes and the relevance to
benzene toxicology must await the results
offurther experiments.
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Appendix
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CN~~°~O CN~~ QHOH
MeR2C CH(CH3)2
2a 2b 2c
N HOH
CBZHN/C02M8 HO2C CH(CH3)2
CBZH -_ 02Me
2d 2e
0
H23 H3 3b$-CH3
3a 3b
Structures la-3b. Structures of muconaldehyde isomers (la-1c), 2-amino-4-
hydroxy-6-methylpyrimidine (3a) and pyrrole adducts (2a-2e, and 3b) derived
from (ZZ)-muconaldehyde with an amine oraminoacid.
OH O
4a AcO OAc 4b c
OH 0
OH
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Structures 4a-7b. Structures of pyrrole adducts (4a-4d, 5a, 5b, 6, 7a, and 7b)
derived from (Z,Z)-muconaldehyde with a nucleoside or related compound.
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